-+ 0.00%
-+ 0.00%
-+ 0.00%

SILO PHARMA ACHIEVES KEY MILESTONE WITH FIRST DOSING IN IND-ENABLING GLP STUDY FOR SPC-15 AS A GROUNDBREAKING PTSD TREATMENT

Reuters·03/26/2025 12:40:07

Please log in to view news